For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on July 4th, 2025 | 07:00 CEST
Over 100% gains! Better than RENK and DroneShield shares? NATO contract for drone insider tip: Volatus Aerospace!
Changing of the guard for defense stocks? While RENK shares have lost more than 20% in recent weeks, drone specialists DroneShield and Volatus Aerospace have exploded. Volatus remains relatively inexpensive. Now, the Company has also secured a NATO contract. In terms of valuation, the Canadians remain something of a hidden gem – their peer group is valued significantly higher. That includes DroneShield. The Australians are now valued at more than AUD 2 billion. Admittedly, their pipeline is also impressive. In addition to the drone revolution, a lot of money continues to flow into tanks and other armored vehicles. The German Armed Forces alone plans to procure thousands of new vehicles. RENK wants a large slice of the billion-dollar pie and is investing EUR 500 million. Does this mean the consolidation is now over?
Read
Commented by Fabian Lorenz on July 3rd, 2025 | 07:05 CEST
Plug Power +71%! CAUTION with Evotec! Buy Walmart partner MiMedia shares?
A 71% share price increase in one month. Is this the resurrection of Plug Power shares? The performance is certainly impressive: operational news, insider buying, and a short squeeze are creating a dynamic mix. However, the fundamental problems remain. Those looking for an exciting stock for the second half of the year should take a closer look at MiMedia. The report on the first six months of this cloud hidden gem is expected to be positive and could drive the stock to a new high after its sideways movement. And what is Evotec doing? After last week's positive news, hopes for an upward trend were high. However, analysts are warning of a possible profit warning at the biotech company.
Read
Commented by Fabian Lorenz on June 30th, 2025 | 07:15 CEST
Buy cleantech stock dynaCERT, or go with Steyr Motors, Deutz - or perhaps Rheinmetall and Nel?
Rheinmetall is the clear leader in the defense sector. However, its stock has already performed very well. It is worth taking a look at second-tier candidates such as Steyr Motors and Deutz. The former has just strengthened its sales in the US. Analysts believe Deutz shares could break through the EUR 10 mark. And in the hydrogen sector? Old favorites Nel ASA and Plug Power are fighting for survival. Analysts see potential for growth at dynaCERT. The hydrogen-based retrofit kit for heavy-duty diesel engines saves customers money and allows them to sell emission certificates. With new German management, sales efforts in Europe are currently being ramped up. Revenues could nearly double within a year. And the stock?
Read
Commented by Fabian Lorenz on June 27th, 2025 | 07:00 CEST
Almonty Industries shares EXPLODE! Rheinmetall, Renk, and Hensoldt left in the shadows!
Almonty Industries' share price has gained over 20% in recent days. On its current home exchange in Toronto, the market capitalization has now surpassed the important CAD 1 billion mark. The upcoming IPO on the NASDAQ is a contributing factor to the price surge, but there are many other reasons! The shares of what will soon be the largest tungsten producer outside China are in a perfect storm of positive momentum. The 5% defense spending target agreed upon by NATO countries is also pushing the stock higher. The shares still appear to be an attractive buy. Analyst price targets have not yet been reached and are likely to be raised soon. Almonty currently overshadows Rheinmetall, Renk, and Hensoldt – and rightly so.
Read
Commented by Fabian Lorenz on June 26th, 2025 | 07:35 CEST
Sensational news drives shares: RENK, BYD, and Desert Gold
A major announcement from Desert Gold: the gold explorer has secured another exciting project. In an interview, the CEO expressed strong optimism. The new asset offers synergies with the Company's existing mega-project, which is nearing a PEA. The goal is to become a gold producer by 2026 - significantly increasing the likelihood of a takeover. RENK & Co. benefited yesterday from the NATO meeting and a cheerful Donald Trump. The confirmation of the 5% target for defense spending caused defense stocks to rise. In contrast, BYD shares remain weak. The Chinese are rushing from one sales record to another – or were they rushing? Because they seem to be falling victim to their own strategy. Investors are fleeing.
Read
Commented by Fabian Lorenz on June 25th, 2025 | 07:30 CEST
BioNTech swallows CureVac! Evotec and Vidac Pharma next? Price driver takeover and Buy recommendation
Is Vidac Pharma about to see another price explosion? Last fall, the share rose by around 200%. Yesterday, there was a "Buy" recommendation. Analysts see potential for growth in this biotech gem. The latest news on the drug candidate VDA 1102 for brain tumors is promising. Could a takeover be on the cards? CureVac's share price has nearly doubled since the beginning of April. BioNTech plans to acquire its mRNA competitor and thus end patent disputes. Evotec is a permanent fixture on the takeover merry-go-round. However, this currently seems to be the only hope for rising share prices. The management's new strategy has not created the hoped-for wave of optimism. Is it still worth buying now?
Read
Commented by Fabian Lorenz on June 24th, 2025 | 07:10 CEST
FOCUS online reports on miracle concrete: Argo Living Soils is working on a revolution in construction!
The construction industry is under enormous pressure: infrastructure is aging, the demand for new buildings is growing - and at the same time, CO₂ emissions must be reduced urgently. This presents opportunities for innovators to earn billions. Argo Living Soils is one such innovator. Nanomaterials are being used to create a miracle concrete which could revolutionize the construction industry. The potential has even been recognized by FOCUS Online, which recently reported on the project in detail. The article not only highlights the technological innovation surrounding graphene concrete but also emphasizes Argo's role as the driving force behind its development. The enormous potential relative to the valuation of EUR 10 million speaks in favor of buying the stock.
Read
Commented by Fabian Lorenz on June 23rd, 2025 | 07:10 CEST
DRONE STOCK: Volatus Aerospace benefits from NATO billions - and much more! BUY RECOMMENDATION!
The drone revolution has only just begun. In Ukraine, remote-controlled aircraft have become a game changer in modern warfare. Defense is just one of many industries being disrupted by drones equipped with the latest camera technology and AI. These all-rounders can transport goods to remote areas, inspect buildings and bridges for structural damage, and even act as aerial fire extinguishers during high-rise fires. One insider tip in this billion-dollar market is Volatus Aerospace. The Canadian company offers numerous services - from drone pilot training to surveillance - and generates recurring revenue streams. The latest capital increase was oversubscribed and should give the stock fresh momentum. Analysts forecast that revenues will soon exceed CAD 80 million and are issuing a "Buy" recommendation for the stock.
Read
Commented by Fabian Lorenz on June 20th, 2025 | 06:55 CEST
Declaration of war on the pharmaceutical industry? Bayer, Novo Nordisk, and insider tip PanGenomic Health
Has US Health Secretary Robert F. Kennedy Jr. declared war on the traditional pharmaceutical industry? That is certainly what former Trump press secretary and current podcaster Anthony Scaramucci seems to think. The reason for this is the complete overhaul of the US Vaccine Advisory Committee. One company set to benefit from the new US Health Secretary is PanGenomic Health. The Company plans to launch a new digital health and alternative medicine business this year. If it manages to secure even a small share of this billion-dollar market, its share price could multiply. The price target for Novo Nordisk was recently reduced. The stock is working on bottoming out, and there was a success for the blockbuster in the US. Bayer's stock is trending favorably. Regular positive news is currently overshadowing the legal disputes in the US. There was recently some positive news to report there.
Read
Commented by Fabian Lorenz on June 19th, 2025 | 07:05 CEST
Share price speculation thanks to drones and artificial intelligence: Rheinmetall, BioNTech, and NetraMark shares
Drones and artificial intelligence are set to revolutionize entire industries. Listed companies that play a leading role in this transformation hold significant upside potential, such as NetraMark. Using artificial intelligence, the Company helps pharmaceutical and biotech companies shorten development times and reduce costs. NetraMark also aims to help shape industry trends. BioNTech, too, relies on AI for its research, frequently acquiring specialized companies. Perhaps NetraMark will be next? In any case, the Canadians would still be a bargain. Rheinmetall shares, on the other hand, are certainly not cheap. However, the multibillion-euro defense budgets for rearmament in Europe are fueling speculation. In order to be able to deliver not only tanks, howitzers, and ammunition quickly, but also cutting-edge technology, Germany's largest defense contractor is focusing on partnerships. This is evident in its latest partnership, which is expected to enable Rheinmetall to deliver combat and kamikaze drones quickly.
Read